ID

27528

Descripción

Study part: Concomitant Medication Treatment Phase. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Palabras clave

Versiones (1)
  1. 19/11/17 19/11/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

19 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Concomitant Medication Treatment Phase Ropinirole Parkinson Disease 101468/165

Inglés

Concomitant Medication Treatment Phase

1 formularios  
CONCOMITANT MEDICATION
Descripción

CONCOMITANT MEDICATION

Alias
UMLS CUI-1
C2347852
Patient Number
Descripción

Patient Number

Tipo de datos

integer

Alias
UMLS CUI [1]
C1830427
Are there any concomitant medication changes since the start of the study?
Descripción

Concomitant Medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347852
Drug Name
Descripción

Drug Name

Tipo de datos

text

Alias
UMLS CUI [1]
C0013227
Single dose/Unit
Descripción

Single dose

Tipo de datos

text

Alias
UMLS CUI [1]
C1960417
Frequency of this dose
Descripción

dose frequency

Tipo de datos

text

Alias
UMLS CUI [1]
C2826654
Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Indication
Descripción

Indication

Tipo de datos

text

Alias
UMLS CUI [1]
C3146298
Start Date/Time
Descripción

Start Date and Time

Tipo de datos

datetime

Alias
UMLS CUI [1]
C3897500
End Date/Time
Descripción

End Date and Time

Tipo de datos

datetime

Alias
UMLS CUI [1]
C3899266
Volver a la parte superior de la página

Similar models

Concomitant Medication Treatment Phase

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
CONCOMITANT MEDICATION
C2347852 (UMLS CUI-1)
Patient Number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Concomitant Medication
Item
Are there any concomitant medication changes since the start of the study?
boolean
C2347852 (UMLS CUI [1])
Drug Name
Item
Drug Name
text
C0013227 (UMLS CUI [1])
Single dose
Item
Single dose/Unit
text
C1960417 (UMLS CUI [1])
dose frequency
Item
Frequency of this dose
text
C2826654 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Indication
Item
Indication
text
C3146298 (UMLS CUI [1])
Start Date and Time
Item
Start Date/Time
datetime
C3897500 (UMLS CUI [1])
End Date and Time
Item
End Date/Time
datetime
C3899266 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial